188 related articles for article (PubMed ID: 28375587)
1. The impact of hepatitis B virus infection and vaccination on the development of non-Hodgkin lymphoma.
Huang CE; Yang YH; Chen YY; Chang JJ; Chen KJ; Lu CH; Lee KD; Chen PC; Chen CC
J Viral Hepat; 2017 Oct; 24(10):885-894. PubMed ID: 28375587
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studies.
Dalia S; Chavez J; Castillo JJ; Sokol L
Leuk Res; 2013 Sep; 37(9):1107-15. PubMed ID: 23809055
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis virus B and C infections are associated with an increased risk of non-Hodgkin lymphoma: A nested case-control study using a national sample cohort.
Kim M; Lee YK; Park B; Oh DJ; Choi HG
J Med Virol; 2020 Aug; 92(8):1214-1220. PubMed ID: 31825111
[TBL] [Abstract][Full Text] [Related]
5. Risk of all-type cancer, hepatocellular carcinoma, non-Hodgkin lymphoma and pancreatic cancer in patients infected with hepatitis B virus.
Andersen ES; Omland LH; Jepsen P; Krarup H; Christensen PB; Obel N; Weis N;
J Viral Hepat; 2015 Oct; 22(10):828-34. PubMed ID: 25650146
[TBL] [Abstract][Full Text] [Related]
6. Serological hepatitis B virus (HBV) activity in patients with HBV infection and B-cell non-Hodgkin's lymphoma.
Zhou X; Wuchter P; Egerer G; Kriegsmann M; Kommoss FKF; Witzens-Harig M; Kriegsmann K
Eur J Haematol; 2020 May; 104(5):469-475. PubMed ID: 31961011
[TBL] [Abstract][Full Text] [Related]
7. Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018-2022): A real-world, retrospective study.
Li Z; Guo W; Zhao Y; Wang H; Guo J; Li Z; Wang B; Cao L; Xu J; Young KH; Bai O
Cancer Med; 2024 May; 13(10):e7284. PubMed ID: 38752442
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus and risk of non-Hodgkin lymphoma: An updated meta-analysis of 58 studies.
Li M; Gan Y; Fan C; Yuan H; Zhang X; Shen Y; Wang Q; Meng Z; Xu D; Tu H
J Viral Hepat; 2018 Aug; 25(8):894-903. PubMed ID: 29532605
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.
Engels EA; Cho ER; Jee SH
Lancet Oncol; 2010 Sep; 11(9):827-34. PubMed ID: 20688564
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis.
Nath A; Agarwal R; Malhotra P; Varma S
Intern Med J; 2010 Sep; 40(9):633-41. PubMed ID: 19811561
[TBL] [Abstract][Full Text] [Related]
11. Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection.
Ulcickas Yood M; Quesenberry CP; Guo D; Caldwell C; Wells K; Shan J; Sanders L; Skovron ML; Iloeje U; Manos MM
Hepatology; 2007 Jul; 46(1):107-12. PubMed ID: 17526021
[TBL] [Abstract][Full Text] [Related]
12. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.
Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT
Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin's lymphoma in China.
Wang C; Xia B; Ning Q; Zhao H; Yang H; Zhao Z; Wang X; Wang Y; Yu Y; Zhang Y
Ann Hematol; 2018 Mar; 97(3):453-457. PubMed ID: 29188315
[TBL] [Abstract][Full Text] [Related]
14. Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma.
Zhou X; Pan H; Yang P; Ye P; Cao H; Zhou H
BMC Cancer; 2019 May; 19(1):477. PubMed ID: 31113483
[TBL] [Abstract][Full Text] [Related]
15. Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China.
Yang S; Yu C; Chen P; Deng M; Cao Q; Li Y; Ren J; Xu K; Yao J; Xie T; Wang C; Cui Y; Ding C; Tian G; Wang B; Zhang X; Ruan B; Li L
Sci Rep; 2015 Dec; 5():18334. PubMed ID: 26655735
[TBL] [Abstract][Full Text] [Related]
16. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies.
Ni YH; Huang LM; Chang MH; Yen CJ; Lu CY; You SL; Kao JH; Lin YC; Chen HL; Hsu HY; Chen DS
Gastroenterology; 2007 Apr; 132(4):1287-93. PubMed ID: 17433322
[TBL] [Abstract][Full Text] [Related]
17. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers.
Wang F; Xu RH; Han B; Shi YX; Luo HY; Jiang WQ; Lin TY; Huang HQ; Xia ZJ; Guan ZZ
Cancer; 2007 Apr; 109(7):1360-4. PubMed ID: 17326056
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma.
Chen MH; Hsiao LT; Chiou TJ; Liu JH; Gau JP; Teng HW; Wang WS; Chao TC; Yen CC; Chen PM
Ann Hematol; 2008 Jun; 87(6):475-80. PubMed ID: 18327583
[TBL] [Abstract][Full Text] [Related]
19. Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma.
Su TH; Liu CJ; Tseng TC; Chou SW; Liu CH; Yang HC; Wu SJ; Chen PJ; Chen DS; Chen CL; Kao JH
Aliment Pharmacol Ther; 2019 Mar; 49(5):589-598. PubMed ID: 30681172
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma.
Kim JS; Hahn JS; Park SY; Kim Y; Park IH; Lee CK; Cheong JW; Lee ST; Min YH
Yonsei Med J; 2007 Feb; 48(1):78-89. PubMed ID: 17326249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
